PFIZER INC Quarterly Goodwill in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Pfizer Inc quarterly Goodwill history and growth rate from Q1 2010 to Q3 2024.
  • Pfizer Inc Goodwill for the quarter ending September 29, 2024 was $68.6B, a 33.1% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $68.6B +$17B +33.1% Sep 29, 2024 10-Q 2024-11-04
Q2 2024 $68.4B +$16.9B +32.7% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $69.3B +$17.8B +34.6% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $67.8B +$16.4B +31.9% Dec 31, 2023 10-Q 2024-11-04
Q3 2023 $51.5B +$2.09B +4.22% Oct 1, 2023 10-Q 2023-11-08
Q2 2023 $51.6B +$1.68B +3.37% Jul 2, 2023 10-Q 2023-08-09
Q1 2023 $51.5B +$1.27B +2.52% Apr 2, 2023 10-Q 2023-05-10
Q4 2022 $51.4B +$2.17B +4.4% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $49.4B -$48M -0.1% Oct 2, 2022 10-Q 2022-11-09
Q2 2022 $49.9B +$24M +0.05% Jul 3, 2022 10-Q 2022-08-10
Q1 2022 $50.2B +$420M +0.84% Apr 3, 2022 10-Q 2022-05-11
Q4 2021 $49.2B -$348M -0.7% Dec 31, 2021 10-K 2024-02-22
Q3 2021 $49.5B -$10.4B -17.4% Oct 3, 2021 10-Q 2021-11-12
Q2 2021 $49.9B -$8.58B -14.7% Jul 4, 2021 10-Q 2021-08-12
Q1 2021 $49.8B -$8.71B -14.9% Apr 4, 2021 10-Q 2021-05-13
Q4 2020 $49.6B +$1.38B +2.85% Dec 31, 2020 10-K 2023-02-23
Q3 2020 $59.9B +$1.24B +2.11% Sep 27, 2020 10-Q 2020-11-05
Q2 2020 $58.4B +$5.1B +9.55% Jun 28, 2020 10-Q 2020-08-06
Q1 2020 $58.5B +$5.02B +9.38% Mar 29, 2020 10-Q 2020-05-07
Q4 2019 $48.2B +$5.25B +12.2% Dec 31, 2019 10-K 2022-02-24
Q3 2019 $58.7B +$3.05B +5.49% Sep 29, 2019 10-Q 2019-11-07
Q2 2019 $53.4B -$2.48B -4.45% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $53.5B -$2.91B -5.15% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $42.9B -$13B -23.3% Dec 31, 2018 10-K 2021-02-25
Q3 2018 $55.6B -$464M -0.83% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $55.8B +$822M +1.49% Jul 1, 2018 10-Q 2018-08-09
Q1 2018 $56.4B +$1.74B +3.18% Apr 1, 2018 10-Q 2018-05-10
Q4 2017 $56B +$1.5B +2.76% Dec 31, 2017 10-K 2020-02-27
Q3 2017 $56.1B -$203M -0.36% Oct 1, 2017 10-Q 2017-11-09
Q2 2017 $55B +$4.41B +8.72% Jul 2, 2017 10-Q 2017-08-10
Q1 2017 $54.7B +$6.1B +12.6% Apr 2, 2017 10-Q 2017-05-11
Q4 2016 $54.4B +$6.21B +12.9% Dec 31, 2016 10-K 2019-02-28
Q3 2016 $56.3B +$9.06B +19.2% Oct 2, 2016 10-Q 2016-11-10
Q2 2016 $50.6B +$9.03B +21.7% Jul 3, 2016 10-Q 2016-08-11
Q1 2016 $48.6B +$6.7B +16% Apr 3, 2016 10-Q 2016-05-12
Q4 2015 $48.2B +$6.17B +14.7% Dec 31, 2015 10-K 2018-02-22
Q3 2015 $47.2B +$4.49B +10.5% Sep 27, 2015 10-Q 2015-11-05
Q2 2015 $41.6B -$1.09B -2.56% Jun 28, 2015 10-Q 2015-08-06
Q1 2015 $41.9B -$613M -1.44% Mar 29, 2015 10-Q 2015-05-07
Q4 2014 $42.1B -$450M -1.06% Dec 31, 2014 10-K 2017-02-23
Q3 2014 $42.7B +$324M +0.76% Sep 28, 2014 10-Q 2014-11-06
Q2 2014 $42.7B +$230M +0.54% Jun 29, 2014 10-Q 2014-08-07
Q1 2014 $42.5B -$1.29B -2.94% Mar 30, 2014 10-Q 2014-05-08
Q4 2013 $42.5B -$1.14B -2.62% Dec 31, 2013 10-K 2015-02-27
Q3 2013 $42.4B -$1.97B -4.44% Sep 29, 2013 10-Q 2013-11-08
Q2 2013 $42.4B -$2.14B -4.8% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $43.8B -$1.5B -3.32% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $43.7B -$908M -2.04% Dec 31, 2012 10-K 2015-02-27
Q3 2012 $44.4B -$1.04B -2.29% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $44.6B -$539M -1.2% Jul 1, 2012 10-Q 2012-08-09
Q1 2012 $45.3B +$399M +0.89% Apr 1, 2012 10-Q 2012-05-10
Q4 2011 $44.6B +$1.14B +2.62% Dec 31, 2011 10-K 2014-02-28
Q3 2011 $45.4B +$1.62B +3.7% Oct 2, 2011 10-Q 2011-11-10
Q2 2011 $45.1B +$1.97B +4.56% Jul 3, 2011 10-Q 2011-08-11
Q1 2011 $44.9B +$2.21B +5.17% Apr 3, 2011 10-Q 2011-05-12
Q4 2010 $43.4B Dec 31, 2010 10-K 2013-02-28
Q3 2010 $43.8B Oct 3, 2010 10-Q 2010-11-12
Q2 2010 $43.1B Jul 4, 2010 10-Q 2010-08-12
Q1 2010 $42.6B Apr 4, 2010 10-Q 2010-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.